Ac-ILRTQESEC-NH2

Ref. 3D-PP49578

Informação sobre produto

• Nome: Ac-ILRTQESEC-NH2

Descrição

Peptide Ac-ILRTQESEC-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-ILRTQESEC-NH2 include the following: Development of live vaccine based on the Enterococcus faecium L3 vector for prevention influenza infections Y Desheva, G Leontieva, T Kramskaya, T Gupalova - 2021 - researchsquare.comhttps://www.researchsquare.com/article/rs-749575/latest A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains TM Doyle, C Li, DJ Bucher, AM Hashem - Biochemical and , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X13017130 Universal anti-neuraminidase antibody inhibiting all influenza A subtypes TM Doyle, AM Hashem , C Li, G Van Domselaar - Antiviral research, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166354213002660 A universal monoclonal antibody protects against all influenza A and B viruses by targeting a highly conserved epitope in the viral neuraminidase TM Doyle, AM Hashem , C Li, DJ Bucher - BMC Genomics, 2014 - Springerhttps://link.springer.com/article/10.1186/1471-2164-15-S2-P8 In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen TJ Wohlbold, F Krammer - Viruses, 2014 - mdpi.comhttps://www.mdpi.com/1999-4915/6/6/2465Despite The influenza virus neuraminidase as a vaccine antigen and the potential of neuraminidase antibodies to protect against infection TJ Wohlbold - 2019 - search.proquest.comhttps://search.proquest.com/openview/77707be8e3b48eef900b9b6bc531e34a/1?pq-origsite=gscholar&cbl=18750 Influenza B virus neuraminidase: a potential target for next-generation vaccines? THT Do, AK Wheatley , SJ Kent - Expert Review of , 2024 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/14760584.2023.2290691 Cross-reactive antibodies against H7N9 and H5N1 avian influenza viruses in Thai population L Jiang , D Changsom, H Lerdsamran - Asian Pacific Journal , 2017 - apjai-journal.orghttps://www.apjai-journal.org/wp-content/uploads/2016/10/AP0788.pdf Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins L Jiang , D Changsom, H Lerdsamran, W Wiriyarat - Archives of , 2016 - Springerhttps://link.springer.com/article/10.1007/s00705-016-2968-7 Prospects of using conservative linear B-cell epitopes of influenza virus A neuraminidase for induction of cross-protective immune response IА Sychev, PM Kopeikin, EV Tsvetkova - Medical academic , 2021 - journals.eco-vector.comhttps://journals.eco-vector.com/MAJ/article/view/76614 Induction of cross-reactive antibodies in mice immunized with conserved influenza A virus neuraminidase-derived linear B-cell epitopes IA Sychev, PM Kopeikin, EV Tsvetkova - Russian Journal of , 2021 - iimmun.ruhttps://iimmun.ru/iimm/article/view/1343 Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1 GE Smith, DC Flyer, R Raghunandan, Y Liu, Z Wei - Vaccine, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X13009870 Antibodies directed toward neuraminidase N1 control disease in a mouse model of influenza ER Job, M Schotsaert , LI Ibaaca±ez , A Smet - Journal of , 2018 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01584-17 Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches CM Thompson, E Petiot , A Lennaertz, O Henry - Virology journal, 2013 - Springerhttps://link.springer.com/article/10.1186/1743-422X-10-141 Titre CM Thompson, E Petiot , A Lennaertz - 2013 - core.ac.ukhttps://core.ac.uk/download/pdf/213622642.pdf Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved C Gravel, C Li, J Wang, AM Hashem , B Jaentschke - Vaccine, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X10009035 A broadly protective anti-influenza neuraminidase monoclonal antibody (VAC11P. 1100) A Hashem , T Doyle, C Li, G Van Domselaar - The Journal of , 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/194/1_Supplement/212.8/55950

• Marca: Biosynth